Commercial

DxTerity’s objective is to deliver our powerful genomic testing technology into routine medical care across a broad range of diseases and chronic conditions through key strategic partnerships.

Our Clinical Diagnostic Partner program is designed to establish collaborations with key industry partners having existing capability to rapidly commercialize products in their areas of clinical expertise. Disease areas such as organ-specific cancers, cardiovascular disease, and infectious disease identification are targeted opportunities in which testing with DxDirect™ can deliver high clinical value.

Use DxDirect™ to enhance your business and product offerings:

• Provide a next generation of speed and simplicity to your customers
• Improve competitive advantage with offerings that reduce the total cost of care
• Prepare to expand the market for your products with a test format ideally suited to migrate across the biomedical testing continuum

learn more...